Free Cash Flow for IDEXX Laboratories (IDXX)
Free Cash Flow for IDEXX Laboratories (IDXX): headline value $1.05B · YoY +32.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingFree Cash FlowSwitch metric
Latest period
$1.05B
YoY change
+32.0%
5Y CAGR
+14.3%
Peak year (2025)
$1.05B
Latest annual
$1.05B
Free Cash Flow history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Free Cash Flow history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $1.05B | +32.0% | ||
| 2024 | $798.08M | +3.3% | ||
| 2023 | $772.88M | +96.1% | ||
| 2022 | $394.15M | -38.0% | ||
| 2021 | $636.00M | +17.7% | ||
| 2020 | $540.44M | +77.8% | ||
| 2019 | $303.93M | +9.7% | ||
| 2018 | $277.15M | -6.5% | ||
| 2017 | $296.57M | +9.9% | ||
| 2016 | $269.78M | +102.2% | ||
| 2015 | $133.44M | -23.8% | ||
| 2014 | $175.15M | +4.7% | ||
| 2013 | $167.36M | +3.8% | ||
| 2012 | $161.23M | +33.8% | ||
| 2011 | $120.48M | -13.7% | ||
| 2010 | $139.53M | +20.4% | ||
| 2009 | $115.88M | +117.1% | ||
| 2008 | $53.37M | -22.5% | ||
| 2007 | $68.88M | +79.0% | ||
| 2006 | $38.47M | -58.3% | ||
| 2005 | $92.35M | +45.0% | ||
| 2004 | $63.67M | -36.5% | ||
| 2003 | $100.26M | +13.7% | ||
| 2002 | $88.17M | +204.2% | ||
| 2001 | $28.98M | +127.9% | ||
| 2000 | $12.72M | -68.4% | ||
| 1999 | $40.20M | -2110.0% | ||
| 1998 | -$2.00M | -90.9% | ||
| 1997 | -$22.00M | +478.9% | ||
| 1996 | -$3.80M | -58.2% | ||
| 1995 | -$9.10M | -187.5% | ||
| 1994 | $10.40M | +96.2% | ||
| 1993 | $5.30M | -320.8% | ||
| 1992 | -$2.40M | -57.1% | ||
| 1991 | -$5.60M | — |
Free Cash Flow values are taken from IDEXX Laboratories's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, IDEXX Laboratories (IDXX) free cash flow totalled $1.05B – surged 32.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories free cash flow compounded at +14.3% per year, sustaining 3 straight years of year-over-year growth.
2025 marks the peak free cash flow at $1.05B, with the historical low of -$22.00M recorded in 1997.
IDEXX Laboratories (IDXX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $14.22B.
IDEXX Laboratories Free Cash Flow by Year
IDEXX Laboratories Free Cash Flow 2025: $1.05B
IDEXX Laboratories free cash flow in 2025 was $1.05B, surged 32.0% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Free Cash Flow 2024: $798.08M
IDEXX Laboratories free cash flow in 2024 was $798.08M, edged up 3.3% from 2023.
IDEXX Laboratories Free Cash Flow 2023: $772.88M
IDEXX Laboratories free cash flow in 2023 was $772.88M, surged 96.1% from 2022.
IDEXX Laboratories Free Cash Flow 2022: $394.15M
IDEXX Laboratories free cash flow in 2022 was $394.15M, plunged 38.0% below 2021.
IDEXX Laboratories Free Cash Flow 2021: $636.00M
IDEXX Laboratories free cash flow in 2021 was $636.00M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Free Cash Flow
Companies in the same sector as IDEXX Laboratories, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's free cash flow?
Latest reported free cash flow for IDEXX Laboratories (IDXX) is $1.05B (period ending December 31, 2025).
How has IDEXX Laboratories free cash flow changed year-over-year?
IDEXX Laboratories (IDXX) free cash flow changed +32.0% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories free cash flow?
IDEXX Laboratories (IDXX) free cash flow compound annual growth rate is +14.3% over the most recent 5 years available.
When did IDEXX Laboratories free cash flow hit its highest annual value?
IDEXX Laboratories free cash flow reached its highest annual value of $1.05B in 2025.
What was IDEXX Laboratories free cash flow in 2024?
IDEXX Laboratories (IDXX) free cash flow in 2024 was $798.08M.
What was IDEXX Laboratories free cash flow in 2025?
IDEXX Laboratories (IDXX) free cash flow in 2025 was $1.05B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.